Nordic Nanovector A

Contact
nordicnanovector.com
+47 22 18 33 01

Nordic Nanovector ASA

Kjelsåsveien 168 B
0884 Oslo
Norway
+47 22 18 33 01
nordicnanovector.com
Contact
Profile News
Contact

About Nordic Nanovector A

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.

Read more about Nordic Nanovector A
Facts about Nordic Nanovector A
  • Focus : Manufacturer
  • Industry : Pharma

News about Nordic Nanovector A

Nordic Nanovector A

04-Jun-2019 | research and development

Nordic Nanovector: European Patent Granted for Betalutin or Humalutin in Combination With Anti-CD20 Antibodies for Treating NHL

Nordic Nanovector ASA announces that the European Patent Organisation (EPO) has granted the company's European Patent covering the use of Betalutin® or ...

Read news
Show more news about Nordic Nanovector A

Here you will find Nordic Nanovector ASA